Aurinia Pharmaceuticals Stock Math Operators Price Series Summation

AUPH Stock  USD 15.22  0.69  4.75%   
Aurinia Pharmaceuticals math operators tool provides the execution environment for running the Price Series Summation operator and other technical functions against Aurinia Pharmaceuticals. Aurinia Pharmaceuticals value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of math operators indicators. As with most other technical indicators, the Price Series Summation operator function is designed to identify and follow existing trends and Immunocore Holdings. Math Operators module provides interface to determine different price movement patterns of similar pairs of equity instruments such as Immunocore Holdings and Aurinia Pharmaceuticals.

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Aurinia Pharmaceuticals Price Series Summation is a cross summation of Aurinia Pharmaceuticals price series and its benchmark/peer.

Aurinia Pharmaceuticals Technical Analysis Modules

Most technical analysis of Aurinia Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Aurinia from various momentum indicators to cycle indicators. When you analyze Aurinia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Aurinia Pharmaceuticals Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Aurinia Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aurinia Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Aurinia Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aurinia Pharmaceuticals's daily price indicators and compare them against related drivers, such as math operators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Aurinia Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Aurinia Pharmaceuticals, we also check how macroeconomic factors affect Aurinia Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2023 2024 2025 2026 (projected)
Payables Turnover3.275.454.95.15
Days Of Inventory On Hand1.0K506.88456.19679.67
Hype
Prediction
LowEstimatedHigh
13.0815.1917.30
Details
Intrinsic
Valuation
LowRealHigh
14.8016.9119.02
Details
Naive
Forecast
LowNextHigh
13.4815.5917.71
Details
6 Analysts
Consensus
LowTargetHigh
15.1716.6718.50
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Insider Screener Now

   

Insider Screener

Find insiders across different sectors to evaluate their impact on performance
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Data Storage Idea
Data Storage
Invested few shares
Manufacturing Idea
Manufacturing
Invested over 60 shares
Macroaxis Index Idea
Macroaxis Index
Invested over 40 shares
Social Domain Idea
Social Domain
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested over 30 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested few shares
When determining whether Aurinia Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aurinia Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aurinia Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aurinia Pharmaceuticals Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aurinia Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Aurinia Stock please use our How to Invest in Aurinia Pharmaceuticals guide.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is there potential for Biotechnology market expansion? Will Aurinia introduce new products? Factors like these will boost the valuation of Aurinia Pharmaceuticals. If investors know Aurinia will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Aurinia Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.3
Earnings Share
0.56
Revenue Per Share
1.941
Quarterly Revenue Growth
0.084
Return On Assets
0.0941
The market value of Aurinia Pharmaceuticals is measured differently than its book value, which is the value of Aurinia that is recorded on the company's balance sheet. Investors also form their own opinion of Aurinia Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Aurinia Pharmaceuticals' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Aurinia Pharmaceuticals' market value can be influenced by many factors that don't directly affect Aurinia Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Aurinia Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aurinia Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Aurinia Pharmaceuticals' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.